Tag: (ASX:CSL)
Paul McKenzie to take reins as CSL’s new CEO, managing director
Global biotechnology giant CSL Limited has named Paul McKenzie as its chief executive officer and managing director, effective 6 March 2023.
CSL makes record 45% profit leap, takes on vaccine manufacturing
As demand for vaccines ramps up, the blood products giant has taken on the enormous task of manufacturing COVID-19 jabs – and so far,...
Featured Article
Data-rich or data-poor: Where should manufacturers focus their AI efforts?
Over the past year, manufacturers worldwide have made significant strides in adopting artificial intelligence technologies, moving beyond the initial hype to tangible implementations that deliver real business value.
